VitaDX

Curated by Signal

Early diagnostics for bladder cancer

Overview

VitaDx develops early diagnostics for bladder cancer. The company uses a proprietary protocol that uses digital analysis to analyze urine and detect selective fluorescence around bladder cancer cells. VitaDx claims that this fluorescence detects cells with greater accuracy and sensitivity than traditional staining protocols, even in early stages of the disease.

Key facts

Founded: 2015
Headquarters: Evry Courcouronnes, France
Stage: Sign up to view
Industry: Life Sciences Technology

Business model

3 products and services: Sign up to view

Contact

Phone: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Life Sciences Technology companies

NeuroKyma
Developer of EEG-based neuro markers for detecting brain activity
Life Sciences TechnologyFrance
I-Nside
Provider of smartphone based, point-of-care endoscopic device
Life Sciences TechnologyStrasbourg, France
Gynov
Developer of pharmaceuticals and dietary supplements for women health
Life Sciences TechnologyBordeaux, France

About VitaDX

What does VitaDX do?

VitaDx develops early diagnostics for bladder cancer.

Where is VitaDX headquartered?

VitaDX is headquartered in Evry Courcouronnes, France.

When was VitaDX founded?

VitaDX was founded in 2015.

Which sector is VitaDX in?

VitaDX operates in Life Sciences Technology.

Who are VitaDX's competitors?

Companies similar to VitaDX include NeuroKyma, I-Nside, and Gynov.